S&P 500   3,380.16 (+0.18%)
DOW   29,398.08 (-0.09%)
QQQ   234.64 (+0.29%)
S&P 500   3,380.16 (+0.18%)
DOW   29,398.08 (-0.09%)
QQQ   234.64 (+0.29%)
S&P 500   3,380.16 (+0.18%)
DOW   29,398.08 (-0.09%)
QQQ   234.64 (+0.29%)
S&P 500   3,380.16 (+0.18%)
DOW   29,398.08 (-0.09%)
QQQ   234.64 (+0.29%)
Log in

Adaptimmune Therapeutics SEC Filings & 10K Form (NASDAQ:ADAP)

$4.02
+0.05 (+1.26 %)
(As of 02/17/2020 01:32 PM ET)
Today's Range
$3.82
Now: $4.02
$4.05
50-Day Range
$1.16
MA: $3.15
$4.52
52-Week Range
$0.71
Now: $4.02
$6.00
Volume524,619 shs
Average Volume1.08 million shs
Market Capitalization$420.85 million
P/E RatioN/A
Dividend YieldN/A
Beta1.43

SEC Filings

Adaptimmune Therapeutics (NASDAQ:ADAP) SEC Filings

DateFilerForm TypeView
02/07/2020
3:20 PM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/28/2020
3:52 PM
Adaptimmune Therapeutics (Issuer)
Florence Anthony A. Jr. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2020
3:52 PM
Adaptimmune Therapeutics (Issuer)
Behbahani Ali (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2020
3:51 PM
Adaptimmune Therapeutics (Issuer)
BASKETT FOREST (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2020
4:31 PM
Adaptimmune Therapeutics (Filer)
Form 424B5
01/22/2020
4:30 PM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/21/2020
4:21 PM
Adaptimmune Therapeutics (Filer)
Form 424B5
01/17/2020
8:48 PM
Adaptimmune Therapeutics (Issuer)
Norry Elliot (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2020
8:35 PM
Adaptimmune Therapeutics (Issuer)
TAYTON-MARTIN HELEN KATRINA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2020
8:33 PM
Adaptimmune Therapeutics (Issuer)
Lunger John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2020
8:31 PM
Adaptimmune Therapeutics (Issuer)
Bertrand William C JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2020
8:30 PM
Adaptimmune Therapeutics (Issuer)
Rawcliffe Adrian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2020
7:03 PM
Adaptimmune Therapeutics (Issuer)
Norry Elliot (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2020
7:03 PM
Adaptimmune Therapeutics (Issuer)
Bertrand William C JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2020
7:02 PM
Adaptimmune Therapeutics (Issuer)
TAYTON-MARTIN HELEN KATRINA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2020
7:02 PM
Adaptimmune Therapeutics (Issuer)
Lunger John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2020
7:01 PM
Adaptimmune Therapeutics (Issuer)
Rawcliffe Adrian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2020
7:01 PM
Adaptimmune Therapeutics (Issuer)
Noble James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2020
5:17 AM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2020
7:02 PM
Adaptimmune Therapeutics (Issuer)
Norry Elliot (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/13/2020
7:42 AM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2020
6:09 AM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2020
7:01 PM
Adaptimmune Therapeutics (Issuer)
Lunger John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2020
7:01 PM
Adaptimmune Therapeutics (Issuer)
Bertrand William C JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2020
7:00 PM
Adaptimmune Therapeutics (Issuer)
Rawcliffe Adrian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2019
10:55 AM
Adaptimmune Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2019
6:35 AM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2019
8:30 PM
Adaptimmune Therapeutics (Issuer)
Garone Michael (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/01/2019
7:14 AM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2019
7:59 AM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2019
11:15 PM
Adaptimmune Therapeutics (Filer)
Form EFFECT
09/03/2019
8:00 PM
Adaptimmune Therapeutics (Issuer)
Rawcliffe Adrian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2019
12:06 PM
Adaptimmune Therapeutics (Subject)
Citibank,N.A./ADR (Filed by)
Form F-6EF
08/30/2019
11:30 AM
Adaptimmune Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/30/2019
11:26 AM
Adaptimmune Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/27/2019
7:39 AM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2019
8:00 PM
Adaptimmune Therapeutics (Issuer)
Amado Rafael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2019
8:03 PM
Adaptimmune Therapeutics (Issuer)
Lunger John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2019
8:02 PM
Adaptimmune Therapeutics (Issuer)
Lunger John (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/01/2019
10:59 AM
Adaptimmune Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2019
6:23 AM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2019
6:22 AM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/25/2019
7:07 AM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/22/2019
7:08 AM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2019
7:11 AM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2019
4:41 PM
Adaptimmune Therapeutics (Issuer)
MOTT DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2019
4:40 PM
Adaptimmune Therapeutics (Issuer)
Behbahani Ali (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2019
4:01 PM
Adaptimmune Therapeutics (Issuer)
Zaks Tal Zvi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2019
4:00 PM
Adaptimmune Therapeutics (Issuer)
Furey John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2019
4:00 PM
Adaptimmune Therapeutics (Issuer)
Kerr Giles Francis Bertram (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2019
4:00 PM
Adaptimmune Therapeutics (Issuer)
Sigal Charles Elliott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2019
4:00 PM
Adaptimmune Therapeutics (Issuer)
Duncan Barbara Gayle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2019
4:00 PM
Adaptimmune Therapeutics (Issuer)
Alleva Lawrence M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2019
7:00 PM
Adaptimmune Therapeutics (Issuer)
Rawcliffe Adrian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2019
7:08 AM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/17/2019
5:00 PM
Adaptimmune Therapeutics (Issuer)
Noble James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2019
7:11 AM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2019
1:57 PM
Adaptimmune Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2019
7:11 AM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2019
6:38 AM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2019
6:08 AM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2019
3:56 PM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2019
6:10 AM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2019
7:10 AM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/15/2019
4:01 PM
Adaptimmune Therapeutics (Filer)
Form DEF 14A
03/01/2019
4:01 PM
Adaptimmune Therapeutics (Filer)
Form PRE 14A
02/27/2019
4:22 PM
Adaptimmune Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/27/2019
4:16 PM
Adaptimmune Therapeutics (Filer)
Form 8-K/A
02/27/2019
6:43 AM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2019
4:00 PM
Adaptimmune Therapeutics (Subject)
Cross Nicholas John (Filed by)
Form SC 13G/A
01/16/2019
8:31 PM
Adaptimmune Therapeutics (Issuer)
Binder-Scholl Gwendolyn Knowlton (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2019
8:31 PM
Adaptimmune Therapeutics (Issuer)
Bertrand William C JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2019
8:31 PM
Adaptimmune Therapeutics (Issuer)
Amado Rafael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2019
8:30 PM
Adaptimmune Therapeutics (Issuer)
Rawcliffe Adrian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2019
8:00 AM
Adaptimmune Therapeutics (Subject)
Matrix Capital Management Company, LP (Filed by)
Form SC 13G/A
01/08/2019
8:02 PM
Adaptimmune Therapeutics (Issuer)
Bertrand William C JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2019
8:01 PM
Adaptimmune Therapeutics (Issuer)
TAYTON-MARTIN HELEN KATRINA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2019
8:01 PM
Adaptimmune Therapeutics (Issuer)
Rawcliffe Adrian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2019
8:01 PM
Adaptimmune Therapeutics (Issuer)
Amado Rafael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2019
8:00 PM
Adaptimmune Therapeutics (Issuer)
Noble James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2019
6:40 AM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2018
7:04 PM
Adaptimmune Therapeutics (Issuer)
Alleva Lawrence M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2018
7:39 AM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2018
9:58 AM
Adaptimmune Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2018
6:36 AM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2018
7:38 AM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2018
3:10 PM
Adaptimmune Therapeutics (Subject)
Matrix Capital Management Company, LP (Filed by)
Form SC 13G/A
10/10/2018
1:37 PM
Adaptimmune Therapeutics (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13D/A
10/02/2018
6:58 PM
Adaptimmune Therapeutics (Issuer)
Binder-Scholl Gwendolyn Knowlton (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2018
2:45 PM
Adaptimmune Therapeutics (Subject)
New Enterprise Associates 14, L.P. (Filed by)
Form SC 13D
09/10/2018
3:49 PM
Adaptimmune Therapeutics (Issuer)
Viswanathan Ravi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2018
3:49 PM
Adaptimmune Therapeutics (Issuer)
Sonsini Peter W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2018
3:49 PM
Adaptimmune Therapeutics (Issuer)
SANDELL SCOTT D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2018
3:48 PM
Adaptimmune Therapeutics (Issuer)
MOTT DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2018
3:48 PM
Adaptimmune Therapeutics (Issuer)
KERINS PATRICK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2018
3:47 PM
Adaptimmune Therapeutics (Issuer)
Florence Anthony A. Jr. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2018
3:47 PM
Adaptimmune Therapeutics (Issuer)
Behbahani Ali (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2018
3:46 PM
Adaptimmune Therapeutics (Issuer)
BASKETT FOREST (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2018
3:46 PM
Adaptimmune Therapeutics (Issuer)
BARRIS PETER J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2018
3:45 PM
Adaptimmune Therapeutics (Issuer)
BARRETT M JAMES (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 2/17/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel